Furthermore, DGKZ activation downstream of mTORC2 in rapamycin-resistant colorectal tumors helps to maintain the DAG/PA balance necessary for cell survival, and DGKZ suppression potentiates the growth-inhibitory effect of rapamycin [25]. This evidence concerns the gene DGKZ and colorectal neoplasm.